Cell Source, Inc. (CLCS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
57 WEST 57TH STREET NEW YORK, NY 10019 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 22,203 | 222,665 | 93,095 | 245,119 | 27,908 | 18,934 | |||
| Cash and cash equivalents | 22,203 | 222,665 | 93,095 | 245,119 | 27,908 | 18,934 | |||
| Prepaid expense | 160,750 | 164,175 | 203,750 | 177,569 | 57,196 | 38,926 | |||
| Other current assets | 12,218 | 23,005 | 16,922 | 29,651 | 29,679 | 7,932 | |||
| Total current assets: | 195,171 | 409,845 | 313,767 | 452,339 | 114,783 | 65,792 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | (2,582) | ||||||||
| Total noncurrent assets: | (2,582) | ||||||||
| Other undisclosed assets | 2,582 | ||||||||
| TOTAL ASSETS: | 195,171 | 409,845 | 313,767 | 452,339 | 114,783 | 65,792 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,492,592 | 2,166,182 | 1,920,251 | 2,182,430 | 1,326,989 | 952,540 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 600,189 | 697,178 | 11,846 | 13,563 | ||
| Taxes payable | ✕ | ✕ | ✕ | 122,457 | 118,017 | 116,401 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 9,750 | 9,750 | 12,000 | |||
| Accounts payable | 1,467,052 | 680,325 | 223,041 | 193,095 | 135,415 | 277,786 | |||
| Accrued liabilities | 25,540 | 1,485,857 | 1,097,021 | 1,159,950 | 1,051,961 | 532,790 | |||
| Debt | 42,033 | 1,676,437 | 4,512,838 | 1,238,000 | 1,111,708 | 1,463,000 | |||
| Deferred compensation liability | 960,554 | 849,898 | 766,102 | 724,185 | 660,863 | 587,734 | |||
| Derivative instruments and hedges, liabilities | 33,000 | 351,900 | 200,500 | ||||||
| Other liabilities | 235,500 | 100,000 | |||||||
| Due to related parties | ✕ | ✕ | 150,000 | 150,000 | 150,000 | 150,000 | 222,000 | ||
| Other undisclosed current liabilities | 2,790,711 | 4,105,106 | 1,874,764 | ||||||
| Total current liabilities: | 2,528,179 | 4,842,517 | 10,139,902 | 8,399,721 | 5,711,724 | 3,525,774 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 6,077,770 | ||||||||
| Long-term debt, excluding current maturities | 6,077,770 | ||||||||
| Other undisclosed noncurrent liabilities | 145,000 | ||||||||
| Total noncurrent liabilities: | 6,077,770 | 145,000 | |||||||
| Other undisclosed liabilities | 13,278,535 | 2,123,453 | 1,460,189 | ||||||
| Total liabilities: | 15,806,714 | 13,043,740 | 10,139,902 | 8,399,721 | 5,856,724 | 4,985,963 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | (15,611,543) | (12,633,895) | (9,826,135) | (7,947,382) | (5,741,941) | (4,920,171) | |||
| Preferred stock | 1,342 | ||||||||
| Common stock | 39,831 | 36,082 | 34,361 | 32,538 | 27,077 | 26,078 | |||
| Additional paid in capital | 26,014,028 | 23,674,354 | 21,316,318 | 17,724,731 | 15,375,565 | 11,723,224 | |||
| Accumulated deficit | (41,667,388) | (36,346,176) | (31,178,428) | (25,705,993) | (21,145,828) | (16,670,333) | |||
| Other undisclosed equity, attributable to parent | 1,986 | 1,845 | 1,614 | 1,245 | 860 | ||||
| Total equity: | (15,611,543) | (12,633,895) | (9,826,135) | (7,947,382) | (5,741,941) | (4,920,171) | |||
| TOTAL LIABILITIES AND EQUITY: | 195,171 | 409,845 | 313,767 | 452,339 | 114,783 | 65,792 | |||
Income Statement (P&L) (USD)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (4,325,346) | (4,175,333) | (4,018,572) | (3,638,036) | (3,902,663) | (2,006,143) | ||
| Operating loss: | (4,325,346) | (4,175,333) | (4,018,572) | (3,638,036) | (3,902,663) | (2,006,143) | ||
| Nonoperating expense | (995,866) | (992,415) | (1,453,863) | (922,129) | (572,832) | (111,303) | ||
| Investment income, nonoperating | 16,977 | (209,655) | ||||||
| Interest and debt expense | 41,920 | (170,868) | (629,201) | 134,202 | 194,245 | (191,251) | ||
| Other undisclosed loss from continuing operations before equity method investments, income taxes | (134,202) | (194,245) | (260,032) | |||||
| Loss from continuing operations before equity method investments, income taxes: | (5,279,292) | (5,338,616) | (6,101,636) | (4,560,165) | (4,475,495) | (2,568,729) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (41,920) | 170,868 | 629,202 | |||||
| Loss from continuing operations before income taxes: | (5,321,212) | (5,167,748) | (5,472,434) | (4,560,165) | (4,475,495) | (2,568,729) | ||
| Income tax benefit | 1,479,115 | 754,660 | 1,771,902 | 2,424,423 | 2,524,179 | 717,000 | ||
| Other undisclosed income from continuing operations | ||||||||
| Loss from continuing operations: | (3,842,097) | (4,413,088) | (3,700,532) | (2,135,742) | (1,951,316) | (1,851,729) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (3,700,532) | (2,135,742) | (1,951,316) | (1,851,729) | |
| Other undisclosed net loss | (1,771,903) | (2,524,179) | ||||||
| Net loss: | (3,842,097) | (4,413,088) | (5,472,435) | (2,135,742) | (4,475,495) | (1,851,729) | ||
| Other undisclosed net loss attributable to parent | (1,479,115) | (754,660) | (2,424,423) | (265,717) | ||||
| Net loss attributable to parent: | (5,321,212) | (5,167,748) | (5,472,435) | (4,560,165) | (4,475,495) | (2,117,446) | ||
| Preferred stock dividends and other adjustments | (1,228,685) | (1,157,486) | (973,205) | |||||
| Other undisclosed net loss available to common stockholders, basic | (877,736) | (741,981) | ||||||
| Net loss available to common stockholders, diluted: | (6,549,897) | (6,325,234) | (6,445,640) | (5,437,901) | (5,217,476) | (2,117,446) | ||
Comprehensive Income (USD)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (3,842,097) | (4,413,088) | (5,472,435) | (2,135,742) | (4,475,495) | (1,851,729) | ||
| Comprehensive loss, net of tax, attributable to parent: | (3,842,097) | (4,413,088) | (5,472,435) | (2,135,742) | (4,475,495) | (1,851,729) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.